Grasustek® contains the active ingredient pegfilgrastim.
Pegfilgrastim is a protein that is produced biotechnologically in bacteria called E. coli. It belongs to a group of proteins called cytokines and is very similar to a natural protein (granulocyte colony-stimulating factor) produced by the body.
Grasustek® is given to adults who are at least 18 years old.
Grasustek® is used to shorten the duration of neutropenia (low white blood cell count) and to reduce the occurrence of neutropenic fever (low white blood cell count associated with fever). These can be caused by the use of cytotoxic chemotherapy (drugs that destroy fast-growing cells). White blood cells are important because they help your body fight infections. These cells are very sensitive to the effects of chemotherapy. This can cause the number of white blood cells in your body to decrease. If the white blood cell count drops to a low level, the body may not have enough of these cells to fight bacteria and you may be at increased risk of infection.
| Strength | Pack size |
| 6 mg | 1 syringe (à 0,6 ml) |
We ask for your understanding that due to the Austrian Medicines Act, certain further information is only accessible to medical professionals.
Login
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from hCaptcha to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Turnstile. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information